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Introduction {#sec001}
============

White-nose syndrome (WNS) is an epizootic disease that has killed millions of bats in North America \[[@ppat.1005168.ref001], [@ppat.1005168.ref002]\]. WNS is caused by the psychrophile *Pseudogymnoascus destructans* (*Pd*) (formerly *Geomyces destructans*), an ascomycete fungal pathogen \[[@ppat.1005168.ref003]--[@ppat.1005168.ref005]\] that affects bats during hibernation. *Pd* grows at temperatures between 2 and 18°C and can infect bats while they hibernate \[[@ppat.1005168.ref004], [@ppat.1005168.ref006]\]. *Pd* is invasive and damages the cutaneous tissues of bats, including the wing \[[@ppat.1005168.ref007]\], forming characteristic cupping erosions that are diagnostic of *Pd* infection \[[@ppat.1005168.ref008]\]. Mortality rates due to WNS vary by species. In the little brown myotis, *Myotis lucifugus*, the mortality rate is up to 91% in affected caves \[[@ppat.1005168.ref009], [@ppat.1005168.ref010]\] whereas WNS resistance has been reported in the big brown bat, *Eptesicus fuscus* \[[@ppat.1005168.ref011]\]. Bats in Europe are exposed to endemic *Pd*, but do not exhibit WNS mortality and appear to be resistant to the disease \[[@ppat.1005168.ref012]\], despite cutaneous invasion by *Pd* \[[@ppat.1005168.ref013]\].

Cutaneous infection by *Pd* causes some species of bats to arouse more frequently from torpor \[[@ppat.1005168.ref005], [@ppat.1005168.ref014], [@ppat.1005168.ref015]\]. Although hibernating mammals spend less than 1% of their time euthermic \[[@ppat.1005168.ref016]\], they use up to 90% of their stored energy during these periods \[[@ppat.1005168.ref017], [@ppat.1005168.ref018]\]. Because each arousal in little brown myotis utilizes an estimated 108 mg of stored fat \[[@ppat.1005168.ref018]\], the increase in arousal frequency caused by WNS explains 58% of the morbidity rate associated with *Pd* infection \[[@ppat.1005168.ref014]\]. Other factors that are also associated WNS pathology include effects of *Pd* infection on the integrity of wing tissue \[[@ppat.1005168.ref007], [@ppat.1005168.ref019]\], electrolyte balance and hydration \[[@ppat.1005168.ref007], [@ppat.1005168.ref020], [@ppat.1005168.ref021]\], chronic respiratory acidosis \[[@ppat.1005168.ref022]\], oxidative stress \[[@ppat.1005168.ref023]\], and immune function \[[@ppat.1005168.ref024]\]. The relative importance of each of these mechanisms in causing death in WNS is not clear, and the most likely model that has emerged is a multi-stage progression of WNS with contributions of several of these factors \[[@ppat.1005168.ref022]\]. Differences in susceptibility to WNS between species in North America may be explained in part by different responses to *Pd* infection such as changes in thermoregulatory behavior. Understanding host responses to *Pd* infection may provide insight that could be useful for improving survival of affected species.

Cutaneous fungal infections in mammals are first recognized by components of the innate immune system, including C-type lectin receptors and Toll-like receptors \[[@ppat.1005168.ref025]\]. Conserved components of the fungal cell wall activate pattern recognition receptors on phagocytes such as neutrophils, macrophages, and dendritic cells, and on epithelial cells \[[@ppat.1005168.ref026]\]. Activation of these cells can lead to induction of the inflammasome, the production of inflammatory cytokines, and generation of reactive oxygen species that can mediate fungal cell killing \[[@ppat.1005168.ref025]\]. The importance of the innate immune response to the initial recognition of fungal infections is demonstrated by the observation that deficiencies in these signaling pathways can lead to chronic fungal infections in humans \[[@ppat.1005168.ref027], [@ppat.1005168.ref028]\]. In the absence of invasion, colonization by commensal fungi can be maintained through tolerance mechanisms mediated by interactions with dendritic cells and epithelial cells in the skin \[[@ppat.1005168.ref029]\]. Local activation of innate immune pathways can slow the growth of invasive pathogenic fungi and promote tolerance, possibly leading to a commensal relationship with the fungus \[[@ppat.1005168.ref030]\], but is not usually sufficient to clear infections. Clearance of infections typically requires T helper (Th) cells, as demonstrated by the susceptibility of patients with acquired immune deficiency syndrome, immunosuppressant therapy, or chemotherapy to fungal infections \[[@ppat.1005168.ref031]\]. These T cell responses can be mediated by Th17 cells \[[@ppat.1005168.ref032], [@ppat.1005168.ref033]\] or, in some cases, Th1 cells \[[@ppat.1005168.ref034]\], with Th2 responses typically associated with greater susceptibility \[[@ppat.1005168.ref035]\]. Th17 responses can contribute to clearance of invasive fungal infections through the actions of IL-17A and IL-22 \[[@ppat.1005168.ref036]\] and the further recruitment and activation of neutrophils \[[@ppat.1005168.ref037]\]. These T cell subsets have not been well characterized in bats, but those T-cell mediated immune mechanisms that have been studied appear to be conserved between bats and other mammals \[[@ppat.1005168.ref038]--[@ppat.1005168.ref041]\].

Fungal infections in animals are typically life-threatening only upon suppression of adaptive immune responses in the host, such as when chytrid fungus (*Batrachochytrium dendrobatidis*) blocks lymphocyte-mediated inflammatory responses \[[@ppat.1005168.ref042]\]. Hibernation produces a natural suppression of some immune responses in mammal species where it has been studied. During hibernation, when the conservation of energy is critical, certain immunological mechanisms are downregulated while others remain unaffected \[[@ppat.1005168.ref043]--[@ppat.1005168.ref051]\]. Changes during hibernation can include depressed antibody responses \[[@ppat.1005168.ref044], [@ppat.1005168.ref052]\], decreased ability of T and B lymphocytes to proliferate in response to challenge \[[@ppat.1005168.ref053], [@ppat.1005168.ref054]\], and reduced complement activity \[[@ppat.1005168.ref047]\]. Hibernation does not affect all immune responses equally, as shown in thirteen-lined ground squirrels (*Ictidomys tridecemlineatus*) that have a suppressed T-independent antibody response but are capable of mounting a T cell-dependent response during hibernation \[[@ppat.1005168.ref044]\]. Studies of transcriptome-wide changes during hibernation in squirrels \[[@ppat.1005168.ref055]--[@ppat.1005168.ref059]\] have shown expression changes in genes involved in metabolism, oxidative stress, protein folding, ischemia/hypoxia, and other processes, but these studies were not examining an active immune response. Hibernation is also known to affect the distribution of leukocytes \[[@ppat.1005168.ref045], [@ppat.1005168.ref060]\] and platelets \[[@ppat.1005168.ref061]\]. However, we have an incomplete understanding of how hibernation affects the suppression, or subsequent recovery, of immune responses \[[@ppat.1005168.ref043]\], or how immune physiology in bats during hibernation may differ from that of rodents.

The cost of immune suppression during torpor is presumably outweighed by the benefits of energy conservation because most pathogens are not capable of proliferating at the low body temperatures of hibernating animals. However, the psychrophilic nature of *Pd* allows it to infect bats within hibernacula \[[@ppat.1005168.ref002], [@ppat.1005168.ref004]\]. The brief euthermic bouts of hibernating bats are shorter than most other hibernating mammalian species \[[@ppat.1005168.ref014], [@ppat.1005168.ref062]\] and it may not be possible for a bat naïve to a pathogen to mount a primary immune response in the few hours that it is euthermic throughout the hibernation season. We have observed antibody responses to *Pd* in bats, but these responses are strongest in active bats exposed to *Pd* after emergence from hibernation \[[@ppat.1005168.ref063]\]. Therefore, hibernating bats may keep pathogens in check by relying on hypothermia, innate immune responses, and/or memory immune responses. The psychrophilic nature of *Pd* overcomes the first of these barriers to infection and the difficulty in fighting fungal pathogens with innate mechanisms alone may allow *Pd* to proliferate and invade the cutaneous tissues of bats.

The WNS panzootic has created an urgent need to understand if North American bat populations can persist in the presence of the fungal pathogen \[[@ppat.1005168.ref001], [@ppat.1005168.ref010]\]. Understanding the complete array of host responses mounted by bats afflicted with WNS may help illuminate sources of variation in survival within and among bat species. To determine which host responses are activated by *Pd* infection, we measured transcriptome-wide gene expression levels in bat wing tissue from hibernating bats affected by WNS. Gene expression was compared to bats that were hibernated in captivity in the absence of *Pd* exposure. We hypothesized that *Pd* infection would cause changes in gene expression that would reveal physiological responses during WNS that might be either protective or pathological. By using next-generation RNA sequencing to examine transcriptome-wide gene expression changes we expected to discover consistent patterns of host responses that occur in *Pd*-infected tissues. Combined with changes in gene expression within the *Pd* pathogen, these results have provided a survey of the host and pathogen interactions occurring during WNS.

Results {#sec002}
=======

Gene Expression Changes Revealed by Next Generation RNA Sequencing {#sec003}
------------------------------------------------------------------

To determine the host response mounted by little brown myotis to *Pd* during hibernation, we measured changes in gene expression at the whole transcriptome level. Wing tissue samples were obtained from hibernating little brown myotis with no known exposure to *Pd* and bats exhibiting physical signs of WNS, as shown in [Table 1](#ppat.1005168.t001){ref-type="table"}. Histopathology \[[@ppat.1005168.ref008]\] and quantitative PCR (qPCR) for *Pd* \[[@ppat.1005168.ref064]\] were used to confirm the WNS status of each bat ([Table 1](#ppat.1005168.t001){ref-type="table"}). Cupping erosions diagnostic of WNS were found on all 6 bats captured in Kentucky, but on none of the 5 bats from states negative for WNS at the time of capture. Low levels of neutrophilic inflammation were found in all 11 wing samples ([Table 1](#ppat.1005168.t001){ref-type="table"}; Infl), although this inflammation was not associated with sites of *Pd* infection. All 6 WNS-affected bats tested positive for *Pd* by qPCR, although the fungal load measured on wing swabs ([Table 1](#ppat.1005168.t001){ref-type="table"}; qPCR) did not correlate with the number of cupping erosions found by histology ([Table 1](#ppat.1005168.t001){ref-type="table"}; WNS). As previously shown \[[@ppat.1005168.ref005], [@ppat.1005168.ref014], [@ppat.1005168.ref015]\], WNS-affected bats had significantly lower body condition ([Table 1](#ppat.1005168.t001){ref-type="table"}; SMI; p = 0.017, t = 2.9255, df = 9).

10.1371/journal.ppat.1005168.t001

###### Samples used for next generation RNA sequencing.

![](ppat.1005168.t001){#ppat.1005168.t001g}

  Sample   Location                        Date Captured   Date Sampled   Sex   Mass   SMI[^1^](#t001fn001){ref-type="table-fn"}   *Pd* Load by qPCR[^2^](#t001fn002){ref-type="table-fn"}   Histology   
  -------- ------------------------------- --------------- -------------- ----- ------ ------------------------------------------- --------------------------------------------------------- ----------- ----
  MI011    Mine in Dickinson Co, MI        5-Nov-2011      22-Mar-2012    M     6.70   6.69                                        Negative                                                  0           9
  MN064    Mine in Saint Louis Co, MN      16-Nov-2011     22-Mar-2012    F     7.41   7.15                                        Negative                                                  0           2
  MN075    Mine in Saint Louis Co, MN      16-Nov-2011     22-Mar-2012    F     7.47   7.68                                        Negative                                                  0           50
  MN090    Mine in Saint Louis Co, MN      16-Nov-2011     22-Mar-2012    M     7.66   7.51                                        Neg/Pos?                                                  0           13
  IL114    Mine in LaSalle Co, IL          17-Nov-2011     22-Mar-2012    F     7.13   7.40                                        Negative                                                  0           2
  KY06     Cave 1 in Breckinridge Co, KY   12-Mar-2014     12-Mar-2014    F     6.04   6.17                                        120 000                                                   352         25
  KY07     Cave 1 in Breckinridge Co, KY   12-Mar-2014     12-Mar-2014    F     6.90   6.89                                        13 000                                                    438         57
  KY11     Cave 1 in Breckinridge Co, KY   12-Mar-2014     12-Mar-2014    M     5.47   6.12                                        169 000                                                   288         3
  KY19     Cave 2 in Breckinridge Co, KY   12-Mar-2014     12-Mar-2014    M     6.28   6.93                                        64 000                                                    117         9
  KY23     Cave 2 in Breckinridge Co, KY   12-Mar-2014     12-Mar-2014    F     6.58   6.89                                        21 000                                                    234         10
  KY39     Cave in Jackson Co, KY          13-Mar-2014     13-Mar-2014    M     6.28   6.69                                        120 000                                                   197         10

^1^ Scaled mass index: (mass(in g))\*(38.01/(forearm length(in mm))\^1.406

^2^ Wing swabs from MI, MN, and IL were measured in duplicate and determined to be positive for *Pd* if the cycle-threshold was less than 40. Samples from KY were quantified in *Pd* genomic equivalents relative to swabs spiked with 10 000 *Pd* conidia.

^3^ Cupping erosions characteristic of WNS per roll of wing tissue.

^4^ Foci of neutrophilic inflammation per roll of wing tissue.

Next generation RNA sequencing (RNA-Seq) was performed using poly-A selected RNA isolated from each RNAlater-preserved wing tissue sample ([S1 Table](#ppat.1005168.s003){ref-type="supplementary-material"}). Using expression levels of *Pd*-derived transcripts, we confirmed that all 6 WNS-affected bats had abundant expression of *Pd* genes. The *Pd*-derived transcripts were not present at significant levels in any of the 5 samples from unaffected bats ([S2 Table](#ppat.1005168.s004){ref-type="supplementary-material"}; p = 2.2x10^-6^, t = 21.5, df = 5.33), including the MN090 sample that had tested positive for *Pd* by qPCR in one of the two replicates ([Table 1](#ppat.1005168.t001){ref-type="table"}). Because high levels of differential expression of *Pd* transcripts would make it more difficult to detect significant changes in host gene expression, the assembly was filtered \[[@ppat.1005168.ref065]\] to remove *Pd*-derived sequences. Comparison of the filtered assembly with the original revealed that removing the *Pd* sequences did not significantly decrease the completeness of the assembly ([S3 Table](#ppat.1005168.s005){ref-type="supplementary-material"}) as determined by BUSCO \[[@ppat.1005168.ref066]\]. This filtered assembly ([S1 Dataset](#ppat.1005168.s012){ref-type="supplementary-material"}) was used to calculate differential expression in host genes between the unaffected and WNS-affected samples.

We compared host gene expression across all samples ([S2 Dataset](#ppat.1005168.s013){ref-type="supplementary-material"}) using DESeq2 \[[@ppat.1005168.ref067]\] to identify transcript clusters that were expressed at a minimum of 2-fold difference and significant at a false discovery rate (FDR) of 0.05 ([S1 Fig](#ppat.1005168.s001){ref-type="supplementary-material"}). We found 1804 transcript clusters that were expressed at higher levels, and 1925 transcript clusters expressed at lower levels, in WNS-affected bat tissues ([S4 Table](#ppat.1005168.s006){ref-type="supplementary-material"}). Hierarchical clustering ([Fig 1](#ppat.1005168.g001){ref-type="fig"}) revealed that expression of these transcripts from all 5 bats without WNS was similar to each other. Gene expression in wing tissue from WNS-affected bats was different from unaffected bats and more similar to each other, as predicted. The normalized expression levels of the 3729 identified transcript clusters differentially expressed are listed in [S4 Table](#ppat.1005168.s006){ref-type="supplementary-material"}.

![Hierarchical clustering of gene expression in WNS-affected and unaffected bats.\
Hierarchical clustering of differentially expressed genes using Pearson correlation complete-linkage clustering. Scale shows Pearson correlation coefficient.](ppat.1005168.g001){#ppat.1005168.g001}

Differential expression of individual gene isoforms was further analyzed using EBSeq \[[@ppat.1005168.ref068]\], an empirical Bayesian approach to modeling gene expression. For each transcript cluster identified as differentially expressed by DESeq2, we used EBSeq to determine if any of the individual transcripts were differentially expressed at a posterior probability greater than 0.99 ([S4 Table](#ppat.1005168.s006){ref-type="supplementary-material"}). Of the 3729 differentially expressed transcript clusters identified by DESeq2, EBSeq identified at least one differentially expressed transcript for 1427 (38% of total, 43% of upregulated genes and 33% of downregulated genes). These results indicate that differences in gene expression are likely due to alternative splicing or other isoform differences for many of the differentially expressed genes.

To annotate the functions of these genes and identify those likely to be involved with host responses to *Pd* infection, we used the Trinotate pipeline. BLAST was used to identify 1365 upregulated transcripts and 325 downregulated transcripts in WNS-affected tissues with significant homology to known genes from vertebrates in the Swissprot database. Of the 2295 remaining transcripts, 13 were mapped to genes from non-vertebrates in the Swissprot database, presumably due to environmental contamination or incomplete removal of *Pd* transcript sequences. Of the 2842 trinity transcript clusters without a BLASTx match in Swissprot, 2731 (96%) were found to align to sequences (e-value \< 0.0001) in the little brown myotis genome. Of the aligned transcripts, 204 (7.4%) were found to correspond to previously identified non-coding RNA sequences. Of the 111 transcript clusters without a transcript that aligned to the little brown myotis genome or Swissprot, BLAST was used to align their transcripts to the UniRef90 database. We found that 7 genes aligned to vertebrate homologs, 9 aligned to fungal homologs, and 15 aligned to other metagenomic sequences. We were unable to identify homologous sequences for any transcripts from 80 (2.1%) of the transcript clusters that were differentially expressed.

Expression levels for the Swissprot-identified transcript clusters with the 100 lowest adjusted p values are shown in [Fig 2](#ppat.1005168.g002){ref-type="fig"} (see [S4 Table](#ppat.1005168.s006){ref-type="supplementary-material"} for all results). Some of the differentially expressed genes with putative functions that were predicted to associate with host responses to a fungal pathogen are listed in [Table 2](#ppat.1005168.t002){ref-type="table"}. WNS caused dramatic changes in expression of genes involved in inflammation, immune responses, wound healing, metabolism, and oxidative stress, even though the bats were hibernating during the *Pd* infection. Most of these genes were upregulated in WNS-affected tissues, while a much smaller number of identified genes with putative functions in these categories were downregulated (Tables [2](#ppat.1005168.t002){ref-type="table"} and [S4](#ppat.1005168.s006){ref-type="supplementary-material"}).

![Global transcriptional analysis of WNS-affected and unaffected bats by RNA-Seq.\
Centered log~2~ fold changes are shown for the 100 most significant differentially expressed identified genes. Adjusted p values ranged from 3.3x10^-5^ to 2.8x10^-18^. The heatmap of TMM-normalized FPKM expression estimates is centered and log~2~ scaled from a minimum of -4.8 to a maximum of 4.8. Transcripts were identified by BLAST alignment to the SwissProt database.](ppat.1005168.g002){#ppat.1005168.g002}
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###### Selected genes differentially expressed in WNS-affected tissues.

![](ppat.1005168.t002){#ppat.1005168.t002g}

  Gene[^1^](#t002fn001){ref-type="table-fn"}   Full Name                                                     FC[^2^](#t002fn002){ref-type="table-fn"}   pvalue[^3^](#t002fn003){ref-type="table-fn"}   padj[^4^](#t002fn004){ref-type="table-fn"}   EB FC[^5^](#t002fn005){ref-type="table-fn"}   PPEE[^6^](#t002fn006){ref-type="table-fn"}
  -------------------------------------------- ------------------------------------------------------------- ------------------------------------------ ---------------------------------------------- -------------------------------------------- --------------------------------------------- --------------------------------------------
  **Inflammation**                                                                                                                                                                                                                                                                                
  IL23A                                        Interleukin-23 subunit alpha                                  32.6                                       4.8E-09                                        2.0E-06                                      33.6                                          1.9E-08
  PGH2                                         Prostaglandin G/H synthase 2 (Cyclooxygenase-2)               30.5                                       1.2E-14                                        2.1E-11                                      42.3                                          3.2E-12
  IL6                                          Interleukin-6                                                 30.3                                       1.1E-10                                        9.9E-08                                      50.9                                          5.2E-09
  MMP25                                        Matrix metalloproteinase-25                                   25.7                                       5.1E-09                                        2.0E-06                                      25.5                                          5.7E-06
  CSF3R                                        Granulocyte colony-stimulating factor receptor                23.7                                       1.7E-09                                        9.1E-07                                      31.3                                          6.9E-08
  CCL20                                        C-C motif chemokine 20                                        22.0                                       1.4E-07                                        3.0E-05                                      21.1                                          3.3E-06
  IL20                                         Interleukin-20                                                20.2                                       2.9E-07                                        5.3E-05                                      21.5                                          1.5E-06
  CSF3                                         Granulocyte colony-stimulating factor                         19.1                                       6.8E-08                                        1.8E-05                                      44.4                                          2.3E-07
  IL1B                                         Interleukin-1 beta                                            17.7                                       5.6E-08                                        1.5E-05                                      13.6                                          6.6E-06
  IL1A                                         Interleukin-1 alpha                                           15.4                                       4.5E-05                                        2.1E-03                                      11.4                                          3.1E-04
  PA21                                         Phospholipase A2                                              13.8                                       3.7E-04                                        9.1E-03                                      NA                                            NA
  CCL2                                         C-C motif chemokine 2                                         12.3                                       6.5E-06                                        5.3E-04                                      16.7                                          2.7E-05
  IL17C                                        Interleukin-17C                                               10.3                                       6.5E-07                                        9.6E-05                                      12.7                                          3.0E-05
  IL19                                         Interleukin-19                                                9.0                                        1.4E-04                                        4.7E-03                                      NA                                            NA
  IL24                                         Interleukin-24                                                7.6                                        3.4E-08                                        1.0E-05                                      18.9                                          1.3E-05
  NCF2                                         Neutrophil cytosol factor 2                                   5.7                                        9.9E-05                                        3.8E-03                                      5.0                                           5.6E-04
  PG12A                                        Group XIIA secretory phospholipase A2                         2.7                                        9.4E-07                                        1.3E-04                                      3.1                                           5.7E-07
  S10AC                                        Protein S100-A12                                              2.3                                        9.0E-04                                        1.7E-02                                      NA                                            NA
  **Other Immune Genes**                                                                                                                                                                                                                                                                          
  ABC3G                                        DNA dC-\>dU-editing enzyme APOBEC-3G                          32.4                                       3.9E-12                                        4.7E-09                                      54.2                                          4.1E-10
  LIRA6                                        Leukocyte immunoglobulin-like receptor subfamily A member 6   23.1                                       1.5E-05                                        9.5E-04                                      NA                                            NA
  HPT                                          Haptoglobin                                                   18.9                                       3.3E-05                                        1.7E-03                                      72.2                                          3.9E-08
  CD3G                                         T-cell surface glycoprotein CD3 gamma chain                   14.8                                       6.7E-06                                        5.5E-04                                      NA                                            NA
  CLC4D                                        C-type lectin domain family 4 member D                        12.5                                       7.0E-05                                        2.9E-03                                      NA                                            NA
  PTPRC                                        Receptor-type tyrosine-protein phosphatase C                  12.3                                       1.4E-07                                        3.1E-05                                      16.0                                          1.1E-04
  CLC4E                                        C-type lectin domain family 4 member E                        12.3                                       3.6E-07                                        6.0E-05                                      NA                                            NA
  CLC7A                                        C-type lectin domain family 7 member A                        10.9                                       5.4E-07                                        8.3E-05                                      NA                                            NA
  CO3                                          Complement C3                                                 10.1                                       2.7E-03                                        3.4E-02                                      64.9                                          8.0E-08
  TLR9                                         Toll-like receptor 9                                          8.9                                        1.4E-06                                        1.7E-04                                      6.2                                           2.5E-05
  S10A3                                        Protein S100-A3                                               8.4                                        4.8E-04                                        1.1E-02                                      NA                                            NA
  CLC6A                                        C-type lectin domain family 6 member A                        7.0                                        1.5E-04                                        5.0E-03                                      7.0                                           3.9E-03
  CLC1A                                        C-type lectin domain family 1 member A                        6.5                                        2.4E-06                                        2.6E-04                                      NA                                            NA
  D103A                                        Beta-defensin 103A                                            6.1                                        5.4E-06                                        4.7E-04                                      6.3                                           3.2E-03
  CLC5A                                        C-type lectin domain family 5 member A                        5.1                                        3.3E-04                                        8.3E-03                                      NA                                            NA
  BIRC3                                        Baculoviral IAP repeat-containing protein 3                   3.4                                        7.9E-05                                        3.2E-03                                      4.6                                           3.3E-04
  UNG                                          Uracil-DNA glycosylase                                        -3.8                                       1.0E-03                                        1.8E-02                                      NA                                            NA
  LEG3                                         Galectin-3                                                    -3.4                                       5.0E-08                                        1.4E-05                                      0.28                                          1.0E-10
  **Wound Healing**                                                                                                                                                                                                                                                                               
  SPRR1                                        Cornifin                                                      184.6                                      4.1E-17                                        1.0E-13                                      66.4                                          \< 1E-16
  LCE3C                                        Late cornified envelope protein 3C                            17.5                                       2.1E-09                                        1.1E-06                                      15.0                                          6.2E-05
  FIBB                                         Fibrinogen beta chain                                         15.9                                       1.8E-04                                        5.6E-03                                      67.2                                          5.2E-08
  FIBA                                         Fibrinogen alpha chain                                        12.4                                       1.1E-03                                        1.9E-02                                      88.1                                          1.6E-08
  ARGI1                                        Arginase-1                                                    11.9                                       4.8E-04                                        1.1E-02                                      NA                                            NA
  FIBG                                         Fibrinogen gamma chain                                        11.8                                       1.4E-03                                        2.2E-02                                      48.9                                          1.6E-07
  EPGN                                         Epigen                                                        10.3                                       2.0E-09                                        1.1E-06                                      13.1                                          7.3E-06
  EREG                                         Proepiregulin                                                 8.8                                        6.9E-07                                        1.0E-04                                      10.7                                          4.8E-04
  KLK6                                         Kallikrein-6                                                  8.1                                        3.4E-07                                        5.9E-05                                      9.1                                           4.2E-04
  K1C17                                        Keratin, type I cytoskeletal 17                               5.9                                        1.3E-05                                        8.7E-04                                      6.6                                           3.7E-03
  P63                                          Tumor protein 63                                              3.1                                        2.0E-05                                        1.2E-03                                      16.9                                          9.8E-05
  **Metabolism**                                                                                                                                                                                                                                                                                  
  PLAC8                                        Placenta-specific gene 8 protein                              37.0                                       1.5E-09                                        8.4E-07                                      25.9                                          1.3E-05
  LIPP                                         Pancreatic triacylglycerol lipase                             22.3                                       1.0E-06                                        1.3E-04                                      19.4                                          2.7E-06
  ANGL3                                        Angiopoietin-related protein 3                                17.2                                       1.5E-04                                        4.9E-03                                      NA                                            NA
  APOC4                                        Apolipoprotein C-IV                                           16.1                                       7.9E-05                                        3.2E-03                                      NA                                            NA
  APOC3                                        Apolipoprotein C-III                                          15.8                                       1.8E-04                                        5.5E-03                                      42.5                                          8.7E-07
  APOC2                                        Apolipoprotein C-II                                           14.5                                       3.7E-04                                        9.2E-03                                      45.0                                          6.8E-07
  FFAR2                                        Free fatty acid receptor 2                                    7.7                                        1.8E-05                                        1.1E-03                                      7.3                                           9.1E-04
  HCAR2                                        Hydroxycarboxylic acid receptor 2                             4.0                                        6.9E-04                                        1.4E-02                                      NA                                            NA
  IP6K2                                        Inositol hexakisphosphate kinase 2                            -5.0                                       3.8E-06                                        3.6E-04                                      0.19                                          2.2E-03
  ACACA                                        Acetyl-CoA carboxylase 1                                      -4.2                                       1.1E-03                                        1.9E-02                                      0.16                                          6.7E-03
  **Other Oxidative Stress**                                                                                                                                                                                                                                                                      
  MMP3                                         Stromelysin-1                                                 34.0                                       3.4E-10                                        2.5E-07                                      57.7                                          6.6E-08
  PERT                                         Thyroid peroxidase                                            3.7                                        2.7E-03                                        3.4E-02                                      NA                                            NA
  PRDX2                                        Peroxiredoxin-2                                               3.6                                        1.1E-05                                        7.8E-04                                      NA                                            NA
  HMOX1                                        Heme oxygenase 1                                              3.0                                        5.4E-04                                        1.2E-02                                      8.2                                           1.7E-03

^1^ BLAST hit with the lowest E-value in the Swissprot database. Only genes with E \< 1E-05 were considered.

^2^ Fold change in gene expression of the WNS-affected samples compared to the unaffected samples as determined by DESeq2. Negative values indicate higher expression in the unaffected samples.

^3^ Probability of differential expression determined by DESeq2.

^4^ Adjusted probability of differential expression after Benjamini-Hochberg FDR correction.

^5^ Posterior probability fold change in EBSeq-estimated expression of each transcript in WNS-affected tissues over unaffected tissues. NA indicates that no isoform for that gene was differentially expressed at an FDR \< 0.001

^6^ Posterior probability estimate by EBSeq that the isoform is differentially expressed.

To determine if all 6 little brown myotis with WNS exhibit similar changes in gene expression, we performed clustering analysis of the differentially expressed transcripts ([Fig 1](#ppat.1005168.g001){ref-type="fig"}). To confirm the significance of these patterns of gene expression, bootstrap analysis of clustering was performed \[[@ppat.1005168.ref069]\]. The clustering of the unaffected samples together and the clustering of the WNS-affected samples together was verified with a confidence of 99% ([Fig 3A](#ppat.1005168.g003){ref-type="fig"}). Principal component analysis was performed to better understand the relationships between the transcripts expressed in the 11 samples ([Fig 3B](#ppat.1005168.g003){ref-type="fig"}). All 5 samples from unaffected bats were very similar based on the first three principal components identified, which account for 71% of the variance in these transcripts. The WNS-affected bat samples have more diverse gene expression ([S5 Table](#ppat.1005168.s007){ref-type="supplementary-material"}) and PC1 (accounting for 44% of the variance) differentiates all 6 from the unaffected bat samples. The genes represented by PC1 include those that are more highly expressed in unaffected than WNS-affected wing tissue ([Fig 2](#ppat.1005168.g002){ref-type="fig"}). PC2 (17% of the variance) and PC3 (10% of the variance) distinguish the KY19, KY23, and KY39 samples from the other two WNS-affected samples and from the unaffected samples. The rotation values of principal component analysis ([S5 Table](#ppat.1005168.s007){ref-type="supplementary-material"}) reveal that inflammatory genes made the greatest contribution to PC2. Clustering analysis revealed diverse host responses among the bats infected with *Pd*.

![Clustering of gene expression patterns.\
(A) Bootstrap analysis of regularized-log transformed counts to assign confidence levels to sample clustering. Red values are approximately unbiased p values and green values are bootstrap probabilities. Red boxes indicate clusters supported at a confidence level of 99%. (B) Principal component analysis of regularized-log transformed counts of differentially expressed genes. Black spheres represent unaffected bats and white spheres represent WNS-affected bats.](ppat.1005168.g003){#ppat.1005168.g003}

Metabolic and Inflammatory Immune Pathways Associated with WNS {#sec004}
--------------------------------------------------------------

We next examined the functional pathways that were most affected in little brown myotis infected with *Pd*. For this gene ontology analysis, DESeq2 results on transcript isoforms were used with a higher FDR threshold of 0.1, as is typical for this type of analysis. From WNS-affected bat tissue, 3104 upregulated transcripts were aligned with BLAST to the human Uniprot database. Homologs for these transcripts were identified and a list of 1937 unique Ensembl IDs associated with upregulated genes was generated ([S6 Table](#ppat.1005168.s008){ref-type="supplementary-material"}). GOrilla \[[@ppat.1005168.ref070]\] was used to determine significantly upregulated gene ontology categories from the Uniprot GO ID database ([Table 3](#ppat.1005168.t003){ref-type="table"} and [S7 Table](#ppat.1005168.s009){ref-type="supplementary-material"}) and REVIGO \[[@ppat.1005168.ref071]\] was used to visualize biological processes that were significantly overrepresented in the WNS-affected transcriptome ([Fig 4](#ppat.1005168.g004){ref-type="fig"}). The functional analysis revealed that *Pd* infection increases expression of genes involved in metabolism, defense responses, and other pathways ([Table 3](#ppat.1005168.t003){ref-type="table"}).

10.1371/journal.ppat.1005168.t003

###### Selected over-represented gene ontology biological process categories.

![](ppat.1005168.t003){#ppat.1005168.t003g}

  Category   GO: Biological Process Term                                        p[^1^](#t003fn001){ref-type="table-fn"}   FDR[^2^](#t003fn002){ref-type="table-fn"}   Enrich[^3^](#t003fn003){ref-type="table-fn"}   \# DE[^4^](#t003fn004){ref-type="table-fn"}   \# Cat[^5^](#t003fn005){ref-type="table-fn"}
  ---------- ------------------------------------------------------------------ ----------------------------------------- ------------------------------------------- ---------------------------------------------- --------------------------------------------- ----------------------------------------------
  0051246    regulation of protein metabolic process                            4.2E-15                                   5.3E-11                                     1.46                                           344                                           1810
  0006952    defense response                                                   2.3E-10                                   2.2E-07                                     1.56                                           179                                           881
  0051248    negative regulation of protein metabolic process                   4.3E-10                                   2.9E-07                                     1.61                                           156                                           746
  0080134    regulation of response to stress                                   9.9E-09                                   4.6E-06                                     1.46                                           194                                           1019
  0044403    symbiosis, encompassing mutualism through parasitism               3.4E-08                                   1.2E-05                                     1.64                                           113                                           528
  0006953    acute-phase response                                               3.5E-07                                   8.9E-05                                     4.11                                           15                                            28
  0034097    response to cytokine                                               1.0E-06                                   2.1E-04                                     1.88                                           58                                            237
  0045089    positive regulation of innate immune response                      1.1E-06                                   2.1E-04                                     1.89                                           57                                            232
  0006954    inflammatory response                                              1.1E-06                                   2.1E-04                                     1.81                                           64                                            271
  0030216    keratinocyte differentiation                                       3.8E-06                                   5.4E-04                                     3.14                                           18                                            44
  0070555    response to interleukin-1                                          7.5E-06                                   9.5E-04                                     2.92                                           19                                            50
  0002526    acute inflammatory response                                        8.4E-06                                   1.0E-03                                     3.11                                           17                                            42
  0002755    MyD88-dependent toll-like receptor signaling pathway               1.7E-05                                   1.8E-03                                     2.56                                           22                                            66
  0034162    toll-like receptor 9 signaling pathway                             4.1E-05                                   3.5E-03                                     2.56                                           20                                            60
  0050860    negative regulation of T cell receptor signaling pathway           5.7E-05                                   4.5E-03                                     4.72                                           8                                             13
  2000378    negative regulation of reactive oxygen species metabolic process   8.7E-05                                   6.3E-03                                     3.52                                           11                                            24
  0009913    epidermal cell differentiation                                     9.0E-05                                   6.5E-03                                     2.44                                           20                                            63
  0030593    neutrophil chemotaxis                                              1.3E-04                                   9.1E-03                                     3.02                                           13                                            33
  0002223    stimulatory C-type lectin receptor signaling pathway               2.3E-04                                   1.4E-02                                     2.01                                           27                                            103
  0050878    regulation of body fluid levels                                    2.7E-04                                   1.6E-02                                     1.43                                           88                                            472
  0051005    negative regulation of lipoprotein lipase activity                 2.9E-04                                   1.7E-02                                     7.68                                           4                                             4
  0032480    negative regulation of type I interferon production                3.7E-04                                   2.1E-02                                     2.77                                           13                                            36

^1^ Over-represented p value.

^2^ False discovery rate after Benjamini-Hochberg adjustment for multiple comparisons.

^3^ Enrichment of differentially expressed genes in this category.

^4^ Number of differentially expressed genes in this category identified by GOrilla at a p value cutoff of 0.001.

^5^ Number of genes in this GO category represented in the background set.

![REVIGO treemap summarizing gene ontology biological process categories over-represented in WNS-affected tissues.\
GOrilla was used to identify Gene Ontology Biological Processes that were over-represented among transcripts more highly expressed in WNS-affected tissues at an FDR cutoff of 0.1 ([S6 Table](#ppat.1005168.s008){ref-type="supplementary-material"}). Over-represented categories with p values of less than 0.001 (290 terms) were used to generate a treemap colored by functional category. The size of each rectangle is proportional to the p value for that category.](ppat.1005168.g004){#ppat.1005168.g004}

For the transcripts that showed lower expression in WNS-affected tissue ([Fig 2](#ppat.1005168.g002){ref-type="fig"}), the same analysis was performed. Of the 1152 identified transcripts that were downregulated at an FDR of 0.1, 694 homologous human genes were identified by BLAST and mapped to Ensembl gene IDs ([S6 Table](#ppat.1005168.s008){ref-type="supplementary-material"}). GOrilla did not identify any Biological Process categories that were significantly downregulated in the WNS-affected bat tissue.

Host-Pathogen Interactions during WNS {#sec005}
-------------------------------------

To examine the gene expression of the *Pd* pathogen using a dual RNA-Seq approach \[[@ppat.1005168.ref072]\], we separately generated a genome-guided Trinity assembly ([S3 Dataset](#ppat.1005168.s014){ref-type="supplementary-material"}) with the Broad Institute *G*. *destructans* genome. The reads from each of the WNS-affected tissues were mapped onto this assembly with Bowtie and gene expression estimated using RSEM ([S4 Dataset](#ppat.1005168.s015){ref-type="supplementary-material"}). Expression levels for the *Pd* genes with the greatest variance are shown in [Fig 5](#ppat.1005168.g005){ref-type="fig"}. Hierarchical clustering ([Fig 6](#ppat.1005168.g006){ref-type="fig"}) and principal component analysis ([S2 Fig](#ppat.1005168.s002){ref-type="supplementary-material"}) of the differentially expressed transcripts indicated that *Pd* gene expression was most similar in the wing tissues from bats obtained from the same hibernaculum ([Table 1](#ppat.1005168.t001){ref-type="table"}). The expression patterns of *Pd* genes were more similar for KY06, KY07, and KY11, which corresponds to bats captured in Cave 1 in Kentucky, and for KY19 and KY23, which were captured from Cave 2.

![Transcriptional analysis of *Pd* gene expression on bats with WNS.\
Centered log~2~ fold changes are shown for 100 *Pd* genes with the greatest variance and a minimum TMM-normalized FPKM expression of 1 in all 6 samples. The heatmap is scaled from a minimum of -4.4 to a maximum of 4.4.](ppat.1005168.g005){#ppat.1005168.g005}

![Hierarchical clustering of *Pd* gene expression on bats with WNS.\
Hierarchical clustering of differentially expressed Pd genes using Pearson correlation complete-linkage clustering. Scale shows Pearson correlation coefficient.](ppat.1005168.g006){#ppat.1005168.g006}

The possible functions of the *Pd* genes expressed among the WNS-affected samples were analyzed by sequence homology. We first examined the expression levels of a family of secreted proteases that have been proposed to be involved in Pd virulence \[[@ppat.1005168.ref073], [@ppat.1005168.ref074]\] and found that these alkaline proteases were expressed by *Pd* in all 6 wing samples ([Table 4](#ppat.1005168.t004){ref-type="table"}). Destructin-2 was the most highly expressed isoform in all WNS-affected bat *Pd* samples.

10.1371/journal.ppat.1005168.t004

###### Expression of destructin transcripts in *Pd* growing on WNS-affected bats.

![](ppat.1005168.t004){#ppat.1005168.t004g}

  Isoform             UniProt Match   Protein Name                         Putative Function(s)                  KY06[^1^](#t004fn001){ref-type="table-fn"}   KY07    KY11    KY19    KY23    KY39
  ------------------- --------------- ------------------------------------ ------------------------------------- -------------------------------------------- ------- ------- ------- ------- -------
  GG4320\| c0_g1_i1   ALP_ACRCH       Destructin-2 (Alkaline protease-2)   Subtilisin-family alkaline protease   1004                                         711.7   1038    3696    4437    1157
  GG6167\| c0_g1_i1   ORYZ_ASPCL      Destructin-1 (Alkaline protease-1)   Subtilisin-family alkaline protease   516.8                                        107.4   720.0   779.4   192.4   128.5
  GG5612\| c0_g1_i1   ORYZ_NEOFI      Destructin-3                         Subtilisin-family alkaline protease   8.3                                          19.2    23.6    231.1   26.2    12.9

^1^ Trimmed mean of M-values- (TMM-) normalized expression determined by RSEM in fragments per kilobase of transcript per million mapped reads (FPKM).

We next examined the *Pd* transcript clusters for additional factors that could affect virulence. Alignment by BLAST to the Swissprot and Uniprot90 databases identified 12 056 transcripts with significant homology to known fungal genes ([S8 Table](#ppat.1005168.s010){ref-type="supplementary-material"}). For the remaining 67 *Pd* transcript clusters, Trinotate was not able to identify known functional domains or signal peptides present in these previously uncharacterized *Pd* transcripts. The results from the BLAST alignment were examined for genes known to be involved in processes that could affect *Pd* virulence, such as secreted proteases \[[@ppat.1005168.ref073]--[@ppat.1005168.ref075]\], metal binding proteins \[[@ppat.1005168.ref076]\], fungal cell wall remodeling \[[@ppat.1005168.ref076], [@ppat.1005168.ref077]\], and other virulence factors \[[@ppat.1005168.ref075], [@ppat.1005168.ref077], [@ppat.1005168.ref078]\]. This analysis identified 46 *Pd* genes that could be involved in pathogenesis ([Table 5](#ppat.1005168.t005){ref-type="table"}), including additional secreted proteases that could be involved in tissue invasion.

10.1371/journal.ppat.1005168.t005

###### Possible virulence genes expressed in *Pd* growing on WNS-affected bats.

![](ppat.1005168.t005){#ppat.1005168.t005g}

  *Pd* Gene       UniProt Match   Protein Name                                    Putative Function                         TMM-normalized expression by RSEM (FPKM)                                   
  --------------- --------------- ----------------------------------------------- ----------------------------------------- ------------------------------------------ ------- ------- ------- ------- -------
  GG1839\|c0_g1   MSBP2_ARATH     Membrane steroid-binding protein 2              Antimicrobial peptide response            63.6                                       146.4   30.1    24.8    65.3    48.2
  GG5000\|c0_g1   DUR3_YEAST      Urea active transporter                         Antimicrobial peptide susceptibility      65.7                                       79.5    107.0   51.6    19.8    14.6
  GG5000\|c1_g1   DUR31_SCHPO     Probable urea active transporter 1              Antimicrobial peptide susceptibility      0                                          79.5    0       81.1    102.1   0
  GG680\|c0_g1    GMDG_00178      Uncharacterized protein                         Drug resistance transporter               0                                          29.7    24.4    141.0   175.2   39.8
  GG2580\|c0_g1   SOL5_ALTSO      Bifunctional solanapyrone synthase              Phytotoxin synthesis, Pathogenesis        101.4                                      0       0       157.3   99.2    0
  GG6092\|c0_g1   SOL5_ALTSO      Bifunctional solanapyrone synthase              Phytotoxin synthesis, Pathogenesis        66.4                                       35.8    113.6   714.7   1116    352.5
  GG3668\|c0_g1   TOXA_COCCA      Putative HC-toxin efflux carrier TOXA           Toxin transporter                         20.4                                       0       77.5    143.8   85.0    62.7
  GG3668\|c1_g1   TOXA_COCCA      Putative HC-toxin efflux carrier TOXA           Toxin transporter                         78.6                                       0       74.4    122.5   40.1    0
  GG432\|c0_g1    TOXA_COCCA      Putative HC-toxin efflux carrier TOXA           Toxin transporter                         114.0                                      35.1    54.2    89.5    131.9   53.1
  GG432\|c1_g1    TOXA_COCCA      Putative HC-toxin efflux carrier TOXA           Toxin transporter                         42.5                                       49.0    20.2    66.5    132.5   0
  GG680\|c1_g1    TOXA_COCCA      Putative HC-toxin efflux carrier TOXA           Toxin transporter                         27.1                                       20.9    12.9    148.7   198.9   0
  GG1568\|c0_g1   CHI1_COCP7      Endochitinase 1                                 Fungal cell wall                          305.2                                      26.9    348.1   581.9   46.0    27.2
  GG2156\|c0_g1   YCZ2_SCHPO      Putative mannan endo-1,6-alpha-mannosidase      Fungal cell wall                          32.5                                       6.3     7.7     57.4    214.3   113.9
  GG1843\|c0_g1   ENG1_SCHPO      Endo-1,3(4)-beta-glucanase 1                    Fungal cell wall                          77.7                                       0       62.1    196.4   8.6     26.0
  GG2744\|c0_g1   BGLE_NEOFI      Probable beta-glucosidase E                     Fungal cell wall                          115.2                                      355.1   84.6    65.8    77.6    8.2
  GG2744\|c1_g1   BGLE_NEOFI      Probable beta-glucosidase E                     Fungal cell wall                          0                                          238.0   0       0       124.6   0
  GG4455\|c0_g1   AVR4_PASFU      Race-specific elicitor A4                       Fungal cell wall, Pathogenesis            106.3                                      5.1     158.0   866.6   309.2   166.0
  GG2938\|c0_g1   BGBP_PENMO      Beta-1,3-glucan-binding protein                 Innate immune activation                  121.2                                      85.2    150.4   34.5    68.4    104.5
  GG2938\|c0_g2   BGBP_PENMO      Beta-1,3-glucan-binding protein                 Innate immune activation                  840.1                                      332.2   768.8   783.6   476.6   339.3
  GG6498\|c0_g1   SR1A_PHYPO      Spherulin-1A                                    Manganese binding                         1067                                       629.2   1202    217.1   373.4   6328
  GG3236\|c0_g1   SBNA_RALME      Pd uncharacterized protein L8FZ85               Siderophore biosynthesis                  68.3                                       205.4   60.5    48.3    192.0   0
  GG4315\|c0_g2   FRE3_YEAST      Ferric reductase transmembrane component 3      Siderophore transport, Iron binding       157.9                                      86.4    135.7   76.1    86.4    95.6
  GG5300\|c0_g1   FRE3_YEAST      Ferric reductase transmembrane component 3      Siderophore transport, Iron binding       2422                                       1441    1623    510.9   400.3   197.0
  GG6235\|c0_g1   SIT1_YEAST      Siderophore iron transporter 1                  Siderophore transporter                   0                                          0       0       23.1    135.3   0
  GG6235\|c0_g2   SIT1_YEAST      Siderophore iron transporter 2                  Siderophore transporter                   115.7                                      133.8   170.1   191.2   74.4    107.0
  GG2118\|c0_g2   ZRT1_YEAST      Zinc-regulated transporter 1                    Zinc transporter                          1873                                       1637    1447    924.5   1211    501.3
  GG5016\|c0_g2   ZRT1_YEAST      Zinc-regulated transporter 2                    Zinc transporter                          457.4                                      310.7   449.3   66.9    137.0   564.1
  GG3064\|c0_g1   MIRB_EMENI      Siderophore iron transporter mirB               Response to iron ion starvation           547.5                                      169.3   220.7   136.1   425.8   259.6
  GG861\|c0_g1    MIRB_EMENI      Siderophore iron transporter mirB               Response to iron ion starvation           656.0                                      410.1   712.3   913.4   1324    541.4
  GG4694\|c1_g1   LAC2_PODAS      Laccase-2                                       Melanin biosynthesis                      64.2                                       19.8    329.4   553.8   69.1    179.0
  GG6611\|c0_g1   UREA_ASPFU      Urease                                          Nitrogen metabolism                       49.8                                       0       0       38.8    151.1   222.7
  GG6611\|c1_g1   UREA_ASPFU      Urease                                          Nitrogen metabolism                       0                                          28.2    34.8    28.6    112.6   0
  GG6611\|c3_g1   UREA_ASPFU      Urease                                          Nitrogen metabolism                       0                                          54.8    0       55.7    142.6   0
  GG6612\|c0_g1   UREA_ASPFU      Urease                                          Nitrogen metabolism                       0                                          0       0       499.6   0       0
  GG3518\|c0_g1   ALL2_ASPFU      Major allergen Asp f 2                          Metallopeptidase, Fungal allergen         2789                                       4105    1021    3510    5373    449.6
  GG2311\|c0_g1   PRTA_ASPNG      Aspergillopepsin-2                              Aspartic endopeptidase                    59.3                                       79.9    84.5    709.2   1149    68.8
  GG2082\|c0_g1   PEPA_ASPOR      Aspartic protease pep1                          Secreted aspartic endopeptidase           64.5                                       31.0    45.9    95.5    370.1   0
  GG2082\|c0_g2   PEPA_ASPOR      Aspartic protease pep1                          Secreted aspartic endopeptidase           0.1                                        0.1     0.1     189.7   5.1     0
  GG4492\|c0_g1   CARP_CRYPA      Endothiapepsin                                  Secreted aspartic endopeptidase           648.7                                      460.5   311.8   406.5   423.6   216.0
  GG448\|c0_g1    LAP1_SCLS1      Leucine aminopeptidase 1                        Secreted leucyl endopeptidase             100.7                                      84.0    95.7    283.3   265.6   183.0
  GG788\|c0_g1    SPM1_MAGO7      Subtilisin-like proteinase Spm1                 Secreted serine endopeptidase             956.8                                      952.7   525.5   1260    1176    919.4
  GG2765\|c0_g1   PEPS_ASPPH      Carboxypeptidase cpdS                           Serine carboxypeptidase                   83.2                                       114.5   146.9   775.2   981.3   408.6
  GG3562\|c1_g1   SED4_ARTOC      Tripeptidyl-peptidase SED4                      Serine endopeptidase, Pathogenesis        715.7                                      366.5   690.3   1703    2009    191.9
  GG2259\|c0_g1   SOD6_CANAL      Cell surface superoxide dismutase \[Cu-Zn\] 6   Superoxide metabolism, Pathogenesis       43.5                                       44.6    13.8    556.7   880.6   179.3
  GG4408\|c0_g1   CCPR2_ASPFU     Putative heme-binding peroxidase                Oxidative stress response, Iron binding   1044                                       842.8   477.1   63.0    42.3    421.4
  GG6788\|c0_g1   HOG1_CRYPA      Mitogen-activated protein kinase HOG1           Virulence and conidia formation           735.1                                      816.2   959.1   325.7   373.5   772.8

Because the tissue samples were collected from bats from 6 different hibernacula for this study, it is possible that differences in host or pathogen gene expression reflect differences in the environmental conditions present in each location, including the microbiome. In addition, the housing of the unaffected bats in captivity for 13 weeks prior to analysis could also have affected the microbiome. To examine the differences in the skin microbiome between the bats, we used MG-RAST to identify the lowest common ancestor of metagenomic sequences present ([S8 Table](#ppat.1005168.s010){ref-type="supplementary-material"}). Although there were some differences observed in the bacterial microbiomes present on the wings of the 11 bats, there were no significant changes between the WNS-affected and unaffected samples when bacteria were identified at the class level. Several strains of *Pseudomonas fluorescens* isolated from bat tissues have been identified with *Pd* growth inhibiting properties \[[@ppat.1005168.ref079]\]. MG-RAST analysis showed that *Pseudomonas* species are present in all 11 samples ([S8 Table](#ppat.1005168.s010){ref-type="supplementary-material"}). *P*. *fluorescens* transcripts represented 2.8±0.6% of transcripts identified from gammaproteobacteria and 0.40±0.05% of all bacteria on the wings of unaffected bats and 0.37±0.07% of all bacteria on WNS-affected bats. *P*. *fluorescens* was present on all little brown myotis sampled, but was rare and relative abundance was not statistically different between WNS-affected and unaffected bats (p = 0.49, t = -0.71, df = 9).

Discussion {#sec006}
==========

The comparison of host gene expression between WNS-affected and unaffected little brown myotis clearly demonstrates that *Pd* infection causes physiological responses in wing tissue, where substantial fungal invasion of the skin occurs in WNS-affected bats \[[@ppat.1005168.ref008]\]. The changes in transcript levels that we have observed indicate that host responses to fungal infection remain intact during hibernation and are similar to those observed during the initial stages of fungal infection in euthermic mammals \[[@ppat.1005168.ref032]\]. These host responses include acute inflammation, wound healing, and metabolic changes. Pathogen gene expression varies among bats with WNS, suggesting host-pathogen interactions that mediate pathogenesis. Together, these results lay a foundation to determine which host and pathogen responses contribute to WNS resistance and susceptibility and identify targets to increase survival.

Host Response to *Pd* Infection {#sec007}
-------------------------------

The gene expression changes we observed in the wing tissue of WNS-affected bats are similar to those observed in other cutaneous fungal infections \[[@ppat.1005168.ref080]\]. Cutaneous *Candida albicans* infections in humans and mice typically initiate an immune response by activating pattern recognition receptors of the C-type lectin family \[[@ppat.1005168.ref081]--[@ppat.1005168.ref083]\] and the toll-like receptor family, both of which we found upregulated in WNS-affected bat wing tissue ([S4 Table](#ppat.1005168.s006){ref-type="supplementary-material"}). These included C-type lectin domain (CLEC) family members CLEC4D (MCL), CLEC4E (MINCLE), CLEC7A (Dectin-1), CLEC6A (Dectin-2), and Toll-like receptor 9. In mice and humans, protective host responses to *C*. *albicans* are usually characterized by many of the same cytokines and chemokines \[[@ppat.1005168.ref029]\] that we have found upgregulated in WNS-affected wing tissue, including the cytokines IL-1β, IL-6, G-CSF, IL-23A, and IL-17C. Little brown myotis infected with *Pd* are increasing transcription of the key genes necessary for initiating a host response that provides protection from fungal infection. This clearly demonstrates that hibernation does not prevent innate immune responses in bats infected with *Pd* and that, although they are not closely related to rodents and primates \[[@ppat.1005168.ref041]\], bats respond to fungal infections similarly to these other mammals.

The responses to *Pd* infection within bat wing tissue may be mediated by keratinocytes in the epithelial tissue. Activation of pattern recognition receptors by fungal ligands is expected to induce keratinocytes to produce many of the cytokines that we have found upregulated at the transcript level in WNS-affected bat wing tissue \[[@ppat.1005168.ref084]\]. In addition to the cytokines typically involved in *C*. *albicans* responses described above, keratinocytes are also known to express the chemokine Ccl2 and the cytokines IL-20 and IL-24 in response to pattern recognition receptor activation \[[@ppat.1005168.ref085]\]. Keratinocytes and fibroblasts are also known to exhibit a paracrine loop of IL-1 and IL-6 activation \[[@ppat.1005168.ref086]\] that enhances wound healing and host defense to microbial infection and we found evidence of IL-1 and IL-6 receptor activation in the increased RNA levels for transcription factor p65, NFκB, and P-selectin glycoprotein ligand 1 ([S4 Table](#ppat.1005168.s006){ref-type="supplementary-material"}). Another important cytokine produced by epithelial cells in response to infection is IL-17C \[[@ppat.1005168.ref087]\]. This is an atypical IL-17 family member that is expressed by epithelial cells and causes autocrine responses in the epithelial cells that also express the IL-17RA and IL-17RE heterodimeric IL-17 receptor \[[@ppat.1005168.ref087]\]. The wing tissue transcriptomes from WNS-affected and unaffected bats show similar expression levels of both IL-17RA and IL-17RE ([S2 Dataset](#ppat.1005168.s013){ref-type="supplementary-material"}) and would, therefore, be expected to be responsive to IL-17C. The gene ontology analysis also found evidence for functional enrichment of genes involved in keratinocyte differentiation, presumably due to wound healing responses. Keratinocytes or other epithelial cells in bat wing tissue appear to have responded to the invasion of the epidermis by fungal hyphae.

Genes for pro-inflammatory mediators characterized the innate immune response that we observed in the wing tissue of *Pd* infected bats. Under euthermic conditions this would be expected to provide protection by the recruitment of monocytes and neutrophils, mediated by G-CSF, IL-23A, Ccl2, IL-17C and IL-6 \[[@ppat.1005168.ref088]\], and the initiation of an adaptive Th17 or Th1 response. However, under the constraints of hibernation, responses that require leukocyte migration do not appear to occur in *Pd*-infected bats. We do not find strong evidence of increased expression for genes characteristic of either innate or adaptive leukocytes, except for L-selectin, which is expressed on T cells, and CD177, which is expressed on neutrophils. Lower than expected levels of monocyte, neutrophil, Th1, and Th17 cell recruitment may be related to the sequestration of leukocytes during hibernation \[[@ppat.1005168.ref045]\]. However, we have observed neutrophil recruitment in hibernating little brown myotis in response to another fungal infection ([Table 1](#ppat.1005168.t001){ref-type="table"}). In the histological examination of the current samples, we found neutrophilic inflammation in both WNS-affected and unaffected wing tissue ([Table 1](#ppat.1005168.t001){ref-type="table"}). However, this inflammation did not occur at the sites of *Pd* infection. Curiously, we found a significant increase in WNS-affected tissue for transcripts for CD3γ and CD45 that could be expressed by gamma-delta T cells or other innate lymphocytes that reside in the skin \[[@ppat.1005168.ref089]\]. It is possible that *Pd* is specifically suppressing neutrophil and/or T cell recruitment by interfering with chemotactic signals, similar to the suppression of inflammatory immune responses during chytridiomycosis in amphibians \[[@ppat.1005168.ref042]\]. However, analysis of tissue levels of the cytokines and chemokines is necessary to confirm the secretion of these proteins. Because neutrophils and T cells do not appear to be recruited to sites of *Pd* infection during hibernation, only local inflammatory mediators may be available and they appear to be unable to control the infection in little brown myotis.

In addition to immune responses, hibernating bats also respond to *Pd* infection in other ways. We found transcripts for proteins from many pathways involved in metabolism, signaling, gene expression, transport, migration, and differentiation that were altered in WNS-affected bats ([Fig 4](#ppat.1005168.g004){ref-type="fig"}). We cannot exclude the possibility that some of these differences were due to the different hibernation conditions of the two groups of bats. However, the differential expression of the genes in these pathways demonstrates that they are subject to regulation during hibernation and can respond to infection, tissue damage, and/or environmental changes.

Host responses to fungal infection can be influenced by changes in the pathogen, including gene expression changes in the colonizing fungus, such as *C*. *albicans* \[[@ppat.1005168.ref029]\]. We found significant variability in the gene expression by *Pd*, which is particularly interesting because all *Pd* in North America is presumed to be a clone of the same mating type \[[@ppat.1005168.ref090]\]. The pathogen has adopted different gene expression profiles in the 6 bat tissues ([Fig 5](#ppat.1005168.g005){ref-type="fig"}), perhaps in response to differences in the host environments. Correspondingly, host gene expression patterns also show differences between the WNS-affected tissue samples. Of particular interest is the observation that the cytokine and chemokine genes found in principal component 2 of our PCA analysis ([Fig 3B](#ppat.1005168.g003){ref-type="fig"} and [S5 Table](#ppat.1005168.s007){ref-type="supplementary-material"}) are expressed at very different levels in the 6 *Pd*-infected samples. From this study we cannot determine whether the differences in pathogen gene expression are driven by differences in the host environment or vice versa. Although all 6 WNS-affected bats had visible signs of WNS, had similar *Pd* burdens, and similar histopathology, it is possible that the differences in host or pathogen gene expression that we observed may have affected progression of WNS and survival.

Responses that May Contribute to WNS Mortality {#sec008}
----------------------------------------------

Because the increased frequency of arousals from torpor appears to be a primary cause of WNS mortality \[[@ppat.1005168.ref005], [@ppat.1005168.ref014], [@ppat.1005168.ref022]\], we considered possible mechanisms that could affect torpor bout length. The increased gene expression of IL-1, IL-6, and other pro-inflammatory cytokines mediates a local acute inflammatory response to *Pd*. These cytokines also have systemic effects that modify behavior and thermoregulation \[[@ppat.1005168.ref091]\]. In addition to cytokine and chemokine transcript increases, we also found increased transcripts for the enzyme cyclooxygenase-2 (prostaglandin G/H synthase 2) and both secreted and cytosolic phospholipase A2 that form critical inflammatory lipid mediators such as prostaglandin H~2~. The eicosanoids generated by these enzymes, along with the actions of the upregulated genes kallikrein-6 and cathepsin S, are expected to generate pain and itching by locally activating neuronal nociceptors \[[@ppat.1005168.ref092], [@ppat.1005168.ref093]\]. This, in turn, could affect torpor bout length and/or behavior during periodic arousals. Indeed, we have documented significantly more grooming in WNS-affected bats infected in the wild \[[@ppat.1005168.ref094]\], although a different study on laboratory-infected bats did not find similar behavior changes \[[@ppat.1005168.ref095]\]. Together, the upregulated genes will likely generate an inflammatory microenvironment within the wing that may contribute to the robust wound healing response that we observe in WNS-affected bats. However, inflammation can also play a detrimental role in some diseases \[[@ppat.1005168.ref096]\]. Further tissue damage and subsequent wound healing occurs in surviving bats upon emergence from hibernation \[[@ppat.1005168.ref019]\]. These local affects of inflammation (pain and itching) as well as systemic effects are likely to play a key role in WNS pathology.

In addition to the gene expression changes that may contribute to acute inflammation locally within the epithelial tissues invaded by *Pd*, the systemic release of febrile cytokines such as IL-6 could affect the signals that control hibernation arousal. However, an exogenous pyrogen, lipopolysaccharide, is not able to provoke arousals in hibernating golden-mantled ground squirrels \[[@ppat.1005168.ref097]\], so it may be unlikely that inflammation or febrile cytokines can directly trigger arousal in WNS-affected bats. Intracerebroventricular injection of prostaglandin E~2~ in golden-mantled ground squirrels induces arousal from torpor and a febrile response during an extended periodic arousal \[[@ppat.1005168.ref097]\]. Our observation of increased expression of the enzyme that generates prostaglandin H~2~ may provide a mechanism that explains the shortened torpor bouts in WNS-affected bats, if it can be shown that this enzyme is active in the tissue and produces enough prostaglandin H~2~ to act systemically.

In addition to the changes in expression of genes involved in immune responses and wound healing, we also found significant changes in metabolic genes. We found evidence of gene expression changes consistent with increased fat metabolism, including changes in transcripts for apolipoproteins, lipid transport proteins, protein metabolism, and carbohydrate metabolism. Of particular interest, we found increases in the expression of hydroxycarboxylic acid receptors 2 and 3 that are known to mediate adiponectin secretion \[[@ppat.1005168.ref098]\]. This suggests that infection with *Pd* may directly trigger changes in lipid and carbohydrate metabolism that contribute to WNS pathology. These changes stand in contrast to the changes that have been seen in the brain transcriptome of hibernating horseshoe bats (*Rhinolophus ferrumequinum*) \[[@ppat.1005168.ref099]\] and the brain proteome of hibernating Rickett's big-footed bats (*Myotis pilosus*) \[[@ppat.1005168.ref100]\], which show decreased fat metabolism during torpor. By leading to premature depletion of fat stores, these gene expression changes could contribute to WNS mortality.

The other changes in host gene expression that we observed are consistent with a multi-stage progression model of WNS \[[@ppat.1005168.ref022]\]. We also found support for changes in genes involved in oxidative stress \[[@ppat.1005168.ref023]\] and body fluid levels, which may contribute to WNS progression. Together, the pattern of gene expression changes that we find in little brown myotis with WNS suggests that a combination of maladaptive responses may contribute to mortality. However, the number of upregulated genes involved in the acute inflammatory response suggests that excessive inflammation may also be a factor contributing to pathology even prior to emergence from hibernation when it is suspected to contribute to wing damage \[[@ppat.1005168.ref101]\].

Implications for Future Studies {#sec009}
-------------------------------

The changes in host transcript levels that we have found are presumably caused by physiological responses of the host to infection. However, caution must be used when extending these transcriptional responses to functional mechanisms because the current study does not measure protein or metabolite levels directly. Future studies will be necessary to determine which of the gene expression changes observed affect which host response mechanisms.

The little brown myotis chosen for the WNS-affected samples were exhibiting WNS pathology and appeared unlikely to survive at the time of sample collection. For this reason, it is presently uncertain which of the gene expression changes that we have observed are contributing to protection and which are pathological. Another factor that likely contributes to the variation in gene expression that we observed among the samples collected from free-ranging bats is the time since the most recent arousal from torpor. Prior to collection of each wing tissue sample, bats were artificially aroused for 30 to 120 minutes. This period of arousal is similar in duration to the natural arousals during hibernation for little brown myotis \[[@ppat.1005168.ref014]\], and presumably of sufficient duration for some innate immune responses to occur and for transcript levels to be altered. One reason for this procedure was to avoid disparities between the elapsed time from the most recent arousal bout until tissue collection. For the WNS-affected bats we could not determine when the most recent natural arousal would have occurred, but it would have likely been more recently than in unaffected animals, as affected animals arouse from torpor more frequently \[[@ppat.1005168.ref014]\]. In the current study we cannot resolve whether the changes in gene expression that we observed occurred during the most recent arousal, during previous periodic arousals, or during torpor. Future studies will be needed to determine which of the changes in gene expression that we observed during WNS in bats in the wild also vary in controlled captive hibernation conditions when prior arousal patterns are known. Further studies are also needed to compare the physiological responses in bats exhibiting WNS morbidity to responses in less susceptible bats, such as European species, North American species that are less susceptible like the big brown bat \[[@ppat.1005168.ref011]\], and the remnant populations of little brown myotis that appear to have developed tolerance or resistance to *Pd* \[[@ppat.1005168.ref001]\]. Such studies should point to a path forward for bats in North America to persist in a landscape where *Pd* is endemic.

Conclusions {#sec010}
-----------

Little brown myotis mount a host response to *Pd* infection during hibernation. Which components of this response are protective or contribute to WNS pathology remains to be resolved. The innate immune response we have observed would be expected to promote a Th17-directed adaptive immune response that could clear the infection. However, the energetic constraints of hibernation may prevent little brown myotis from execution of the Th17- and neutrophil-mediated phases of the immune response. This may lead to excessive inflammatory responses, either during hibernation or upon emergence. The changes in host gene expression that we observed demonstrate that during *Pd* infection, little brown myotis also alter other defense responses, metabolic pathways, and transcription. Numerous *Pd* genes that may contribute to virulence were identified and these represent potential pathogen responses to host defense. Hibernation does not prevent a host response to infection and a better understanding of the differences between host and pathogen responses in bats susceptible to WNS and those resistant may lead to ways for increasing survival.

Materials and Methods {#sec011}
=====================

Ethics Statement {#sec012}
----------------

This study was carried out on bats from non-endangered species in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All methods were approved by the Institutional Animal Care and Use Committee at Bucknell University (protocol DMR-016). Animals were humanely euthanized by isoflurane anesthesia overdose followed by decapitation. In Illinois, animal collection was conducted by state wildlife officials and a numbered permit was not required. Scientific collector's permits were obtained in Michigan (SC1448), Minnesota (201174), and Kentucky (SC1411147).

Samples {#sec013}
-------

We collected hibernating little brown myotis from cave or mine walls at the locations listed in [Table 1](#ppat.1005168.t001){ref-type="table"}. Bats collected from all locations are expected to be from the same genetic population of eastern little brown myotis \[[@ppat.1005168.ref102]\]. For bats unaffected by WNS, little brown myotis were first swabbed on the left forearm for quantitative PCR analysis. After measurements were taken, bats were individually placed in cloth bags and hung in constant temperature thermoelectric coolers (Koolatron PC-3) maintained at \~7°C. Water-saturated sponges were placed in the bottom of each cooler to maintain humidity during transportation to Bucknell University. Bats were housed for 13 weeks in a Percival (model I36VLC8) environmental chamber with conditions set to 4°C and 95% relative humidity. Bats were provided water throughout hibernation. Bats were aroused from hibernation for 30--120 minutes prior to euthanasia. For WNS-affected bats, little brown myotis were collected in the field, measured, swabbed for quantitative PCR, and humanely euthanized after being aroused from hibernation for 60--120 minutes. Scaled mass index (SMI) was calculated using the formula (mass(in g))\*(38.01/(forearm length(in mm))\^1.406 \[[@ppat.1005168.ref103]\]. Wing tissue was placed in formalin for histology and placed in RNAlater (Sigma-Aldrich) for gene expression analysis. RNAlater samples were stored at ambient temperature for up to 24 hours before long-term storage at -80°C. RNA was purified from 50 mg of wing tissue using a QIAGEN RNeasy Mini Kit. All samples used for RNA sequencing had RNA integrity values greater than 7.0 using an Agilent Bioanalyzer.

Verification of WNS Status {#sec014}
--------------------------

Wing skin tissue was removed from the bones of the arm and digits and rolled onto 2 cm paraffin wax logs. The logs were then fixed in 10% neutral buffered formalin for at least 24 hours. Each log was cut into 3 pieces that were processed into paraffin blocks overnight in a Tissue-Tek VIP processor (Sakura Finetek). The pieces were embedded in paraffin blocks, sectioned at 3 microns, and stained with periodic acid Schiff with a hematoxylin counterstain \[[@ppat.1005168.ref008]\]. WNS lesions ([Table 1](#ppat.1005168.t001){ref-type="table"}; WNS) were identified as cupping erosions with fungal hyphae and conida present. Inflammatory foci ([Table 1](#ppat.1005168.t001){ref-type="table"}; Infl) were identified as clusters of infiltrating neutrophils and were not associated with the asymmetrical curved conidia of *Pd*.

To determine presence or absence of *Pd* on bats unaffected by WNS, each swab was tested twice by quantitative PCR \[[@ppat.1005168.ref064]\] by Jeffrey T. Foster at University of New Hampshire. A cycle-threshold less than 40 was used as a positive result. One of the 5 unaffected bats had one positive and one negative test ([Table 1](#ppat.1005168.t001){ref-type="table"}), but histology ([Table 1](#ppat.1005168.t001){ref-type="table"}) and subsequent RNA sequencing determined this to most likely be a false positive ([S2 Table](#ppat.1005168.s004){ref-type="supplementary-material"}; p = 2.2x10^-6^). For bats affected by WNS, we performed quantitative PCR to measure the *Pd* load, in genomic equivalents normalized to swabs spiked with 10 000 *Pd* conidia, that were detected on each bat \[[@ppat.1005168.ref015]\].

Next Generation RNA Sequencing {#sec015}
------------------------------

The Genome Sequencing and Analysis Facility at the University of Texas at Austin performed all library preparation and quality control procedures. Directional RNA libraries were prepared with poly-A mRNA enrichment, dUTP/UDG strand-specific labeling, fragmentation, and 200 base pair size selection. RNA-Seq was performed in two lanes of an Illumina HiSeq 2500 with 101 base pair length reads obtained.

Transcriptome Assemblies {#sec016}
------------------------

The paired reads from all samples were preprocessed by removing adapters and using trimmomatic PE \[[@ppat.1005168.ref104]\] with settings of Illumina clip:2:30:10, seed mismatches:2, palindrome threshold:30, clip threshold:10, leading:5, trailing:5, minlength:36. The remaining paired reads were then combined and Trinity (v2.0.4) was used in strand-specific mode (RF) to construct a de novo assembly \[[@ppat.1005168.ref105]\]. K-mer in silico read normalization with maximum coverage of 50 resulted in 22 482 456 read pairs that were used for assembly out of 177 755 004 total. The assembly was then filtered to remove *Pd* sequences using the program Deconseq \[[@ppat.1005168.ref065]\] with the Broad Institute *Geomyces destructans* genome 20631--21 used to identify pathogen sequences and with the little brown myotis genome (Myoluc2.0) used to retain host sequences. Bowtie 1.0.1 \[[@ppat.1005168.ref106]\] was used to determine the number of reads that mapped to each transcript in the assembly.

Differential Expression {#sec017}
-----------------------

The script align_and_estimate_abundance.pl included in the Trinity v2.0.6 distribution \[[@ppat.1005168.ref105]\] was used to estimate expression levels for each transcript. Bowtie 1.0.1 \[[@ppat.1005168.ref106]\] was used to map reads (including unpaired reads after quality trimming) from each sample onto the assembly. RSEM v1.2.20 \[[@ppat.1005168.ref107]\] was used to apply an expectation maximization algorithm to predict gene expression counts for each transcript. Expression levels are presented after trimmed mean of M-values (TMM) normalization in fragments per kilobase of transcript per million mapped reads (FPKM). DESeq2 v1.8.1 \[[@ppat.1005168.ref067]\] was used to determine the probability of differential expression for each Trinity transcript cluster that had a minimum RSEM-estimated count, before normalization, of 5 across all samples. For DESeq2 analysis, the default values for removing outliers and filtering lowly expressed transcripts were used. An alpha value of 0.05 was used instead of the default of 0.1 to decrease the number of differentially expressed genes identified. Posterior probabilities of differential expression for individual transcript isoforms were estimated using a Bayesian approach with EBSeq v1.8.0 \[[@ppat.1005168.ref068]\]. False discovery rate \[[@ppat.1005168.ref108]\] was used to control for multiple comparisons. NCBI BLAST v2.2.29+ \[[@ppat.1005168.ref109]\] was used to identify the highest-ranking match for each isoform in the UniProt Swissprot database (downloaded on Sep 17, 2014) with an e-value cutoff of 1x10^-5^.

Hierarchical clustering of samples and genes was performed within R 3.1.2 using the hclust function with the complete linkage method. Bootstrap analysis of clustering was performed using the pvclust 1.3--2 package and 1000 replications \[[@ppat.1005168.ref069]\]. Principal component analysis was performed using the prcomp function and visualized with the rgl 0.93.1098 package.

Gene Ontology {#sec018}
-------------

NCBI BLAST v2.2.29+ \[[@ppat.1005168.ref109]\] was used with an e-value cutoff of 1x10^-5^ to identify homologs in the Uniprot Swissprot human protein database (downloaded on Nov 25, 2014) for transcripts significantly upregulated in WNS-affected bat wing tissue with an FDR of less than 0.1 (in order to increase the number of genes prior to subsequent analysis with higher stringency FDR). Unique Ensembl gene IDs were identified for 1144 of the 1922 upregulated transcripts and 481 of the 1356 downregulated transcripts. GOrilla \[[@ppat.1005168.ref070]\] was used with a p value cutoff of 0.001 to identify upregulated or downregulated biological processes by comparison to the background list of 12 828 human genes identified by BLAST in the Trinity assembly. Multiple testing correction \[[@ppat.1005168.ref108]\] was used with an FDR cutoff of 0.01. Results were visualized as a treemap with REVIGO \[[@ppat.1005168.ref071]\].

*Pd* Gene Analysis {#sec019}
------------------

Trinity v2.0.4 was used to generate a *Pd* assembly in genome-guided mode with jaccard clipping and using the Broad Institute *G*. *destructans* genome 20631--21. This assembly was used to assess pathogen gene expression in the samples from WNS-affected bats using RSEM v1.2.20 \[[@ppat.1005168.ref107]\]. Trinotate v2 was used to annotate the *Pd* transcripts by using NCBI BLAST v2.2.29+ \[[@ppat.1005168.ref109]\] and both the Swissprot and Uniref90 databases (downloaded on Sep 17, 2014).

Metagenome Analysis {#sec020}
-------------------

Reads for each sample were analyzed using MG-RAST v.3.5 \[[@ppat.1005168.ref110]\] to identify metagenomic sequences after filtering against the *B*. *taurus* genome (the taxonomically closest genome available for filtering). For assignment of organism abundance, the best hit classification was used with the M5NR database, maximum e-value cutoff of 1x10^-5^, minimum identity cutoff of 60%, and minimum alignment length cutoff of 15.

Supporting Information {#sec021}
======================

###### MA plot of gene expression using the trinity transcriptome assembly.

Expression levels for every gene are shown by comparing RSEM-estimated counts to the fold-change in expression between unaffected and WNS-affected bat tissues. Blue points indicate significant differential expression determined by DESeq2 using an FDR cutoff of 0.05. Genes that are more highly expressed in WNS-affected tissues are found in the lower side of the graph.
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###### Principal component analysis of *Pd* genes.

The Trinity utility PtR was used to conduct principal component analysis on the *Pd* genes with a minimum expression of 10 FPKM.
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###### Read statistics of RNA-Seq samples.
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###### FPKM analysis of *Pd*-derived transcripts prior to removal.
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###### Transcriptome assembly comparison.

(DOCX)

###### 

Click here for additional data file.

###### Differentially expressed genes determined by RSEM and DESeq2 combined with EBSeq and trinotate results.
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###### Principal component analysis rotation values.
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###### Differentially expressed genes used for GOrilla analysis.
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###### Gene ontology biological process categories over-represented in WNS-affected tissues.
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###### *Pd* gene expression estimated by RSEM combined with trinotate results.
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###### MG-RAST analysis of best hit classification for bacterial genes.
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###### FASTA file of de novo assembly of little brown myotis transcriptome.
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###### RSEM gene expression matrices used for differential host gene expression calculations.
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###### FASTA file of genome-guided trinity assembly of *Pd* transcriptome.
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###### RSEM gene expression matrices for *Pd* transcripts.
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